Respiratory Syncytial Virus (RSV) Therapeutics Market to Hit US$ 8.73 Billion by 2031 | Exclusive Report by Growth Plus Reports Newark, New Castle, USA, June 21, 2023 (GLOBE NEWSWIRE) -- A recent report by Growth Plus Reports estimated the global respiratory syncytial virus (RSV) therapeutics market to be worth US$ 1.84...